ClinConnect ClinConnect Logo
Search / Trial NCT06798532

Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jan 27, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Neuroblastic Tumors Neuroblastomas Ganglioneuroblastomas Ganglioneuromas Adamkiewicz Artery Pediatric Surgery

ClinConnect Summary

This clinical trial is studying whether using a special imaging test called arteriography before surgery can help identify a critical blood vessel, known as the Adamkiewicz artery, in patients with certain types of tumors in the chest area. These tumors, called neuroblastic tumors, can sometimes press on the spinal cord and cause serious complications during surgery. By figuring out the best way to locate this artery before surgery, the researchers hope to reduce the risk of nerve damage and other problems after the operation.

To be eligible for this trial, participants should be undergoing surgery for a neuroblastic tumor located in the thoracic area of the spine. This includes both children and adults who are being treated in pediatric surgery departments in France. They should also be willing to allow their medical information to be used for the study. Participants can expect to be part of a valuable research effort that may improve the safety of surgeries for these kinds of tumors in the future. The trial is not yet recruiting participants, but it aims to gather important insights over the next few years.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients undergoing surgery for a neuroblastic tumor (neuroblastoma, ganglioneuroblastoma, ganglioneuroma)
  • 2. Basithoracic location between T8 and L1
  • 3. With or without intraspinal component
  • 4. Treated in a pediatric surgery department in France
  • 5. Between 2005 and 2024
  • 6. Adult patients or holders of parental authority of minor patients informed and not opposed to the use of data for the study
  • Exclusion Criteria:
  • 1. Post-operative follow-up of less than 6 months

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Caen, , France

Grenoble, , France

Paris, , France

Tours, , France

Brest, , France

Nantes, , France

Amiens, , France

Limoges, , France

Lille, , France

Bordeaux, , France

Paris, , France

Poitiers, , France

Paris, , France

Nice, , France

Reims, , France

Besançon, , France

Rouen, , France

Dijon, , France

Bron, , France

Le Kremlin Bicêtre, , France

Montpellier, , France

Marseille, , France

Nancy, , France

Rennes, , France

Saint Denis, , France

Strasbourg, , France

Toulouse, , France

Patients applied

0 patients applied

Trial Officials

Marianna MD Cornet

Principal Investigator

Assistance Publique - Hôpitaux de Paris

Sabine MD, PhD Sarnacki

Principal Investigator

Assistance Publique - Hôpitaux de Paris

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported